A groundbreaking clinical trial for visceral leishmaniasis is underway in Liverpool, testing an oral drug (DNDi-6899) that could replace current painful injection treatments requiring hospitalization.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.